Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Oct 21 - Oct 26
The SURMOUNT-1 trial (N=2,539) demonstrated that tirzepatide at doses of 5, 10, and 15 mg produced mean weight losses of 15.0%, 19.5%, and 20.9%, respectively, over 72 weeks
Tirzepatide is the only licenced GLP-1/GIP co-agonist for obesity, with several more GLP-1/GIP co-agonists in development [15]
Talk to a qualified clinician before using any injection
Your body sets the pace
As the body adapts, sleep often improves over time.
US$ 26.45
US$ 28.29
US$ 24.39
US$ 21.62
US$ 25.94
US$ 26.29
US$ 24.96
